Identification of Selective ATP-Competitive CMG Helicase Inhibitors for Cancer Intervention that Disrupt CMG-Replisome Function

The human CMG helicase (Cdc45-MCM-GINS) is a novel target for anti-cancer therapy due to tumor-specific weaknesses in CMG function induced by oncogenic changes and the need for CMG function during recovery from replicative stresses such as chemotherapy. Here, we developed an orthogonal biochemical s...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiang, Shengyan, Luo, Xingju, Welch, Darcy, Reed, Damon R., Alexandrow, Mark G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441460/
https://www.ncbi.nlm.nih.gov/pubmed/37609279
http://dx.doi.org/10.21203/rs.3.rs-3182731/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441460/
https://www.ncbi.nlm.nih.gov/pubmed/37609279
http://dx.doi.org/10.21203/rs.3.rs-3182731/v1

Ejemplares similares